Archive for November, 2011

arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round

ROTTERDAM, the Netherlands and GHENT, Belgium, December 1, 2011 /PRNewswire/ -- Funds will be Used to Progress Differentiated Therapeutic Antibody Programs into Clinical Development arGEN-X, a biopharmaceutical company focused on the discovery and development of human...
READ THE FULL ARTICLE >>

Patients with Overactive Bladder Invited to Participate in the “Virtual Clinical Trial”

CONSHOHOCKEN, Pa., Nov. 30, 2011 /PRNewswire/ -- If you, or someone you know suffers from overactive bladder (otherwise known as OAB or "urge incontinence"), you might qualify for a research study of an approved medication where you can participate from the privacy...
READ THE FULL ARTICLE >>

BioPower Systems Awarded $5 Million from Victorian Government

SYDNEY, Nov. 30, 2011 /PRNewswire/ -- Ocean energy company, BioPower Systems (BPS), today announced that the Victorian Minister for Energy and Resources, the Hon. Michael O'Brien MP, has awarded the company conditional funding support of $5 million under the Sustainable Energy...
READ THE FULL ARTICLE >>

FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor

...
READ THE FULL ARTICLE >>

American Botanical Council Publishes a History of Adulteration

...
READ THE FULL ARTICLE >>

Kewaunee Scientific Announces Results for Second Quarter

STATESVILLE, N.C., Nov. 30, 2011 /PRNewswire/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today announced the financial results for its second quarter ended October 31, 2011. Sales for the quarter were $25,962,000, up 1.3% over sales of $25,625,000 in the second quarter last...
READ THE FULL ARTICLE >>

Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors

...
READ THE FULL ARTICLE >>

Dr. Michael Richman to Analyze the Relevance of MTHFR Polymorphisms in Venous Disease with or without Concomitant Thrombosis

RICHMOND, Va., Nov. 30, 2011 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.) announced today that medical advisory board member Michael F. Richman M.D., F.A.C.S., founder of the Center for Cholesterol Management and The Elite Laser Vein Center in Los Angeles, has...
READ THE FULL ARTICLE >>

XTL Biopharmaceuticals, Ltd. Completes the Acquisition of MinoGuard

HERZELIYA, Israel, November 30, 2011 /PRNewswire/ -- MinoGuard develops drugs to treat mental health diseases. MinoGuard's lead drug for the treatment of schizophrenia patients is intended to improve the efficacy of existing treatments and minimize their side effects. MinoGuard...
READ THE FULL ARTICLE >>

Alameda County Medical Center Strengthens Leadership Team in Legislative Affairs, Marketing and Communications

OAKLAND, Calif., Nov. 30, 2011 /PRNewswire/ -- Alameda County Medical Center (www.acmedctr.com), a leading public health care system based in Oakland and San Leandro, California, announced today that it has hired B. Patricia Barrera, J.D., and Jerri Applegate Randrup as Directors...
READ THE FULL ARTICLE >>
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes